CTIC - シ―ティ―アイ・バイオファ―マ (CTI BioPharma Corp.)

CTICのニュース

   CTI BioPharma to Present at the JMP Securities Life Sciences Conference on Wednesday, June 16  2021/06/09 00:00:00 BioSpace
CTI BioPharma Corp. announced that management will provide a corporate overview at the JMP Securities Life Sciences Conference at 2:30 p.m. ET.
   CTI BioPharma (CTIC) Q1 2021 Earnings Call Transcript  2021/06/02 04:00:26 The Motley Fool
CTIC earnings call for the period ending March 31, 2021.
   CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q1 2021 Results - Earnings Call Transcript  2021/06/02 01:16:04 Seeking Alpha
   CTI Biopharma net loss widens on R&D expenses, preparations for drug launch  2021/06/01 20:47:55 Seeking Alpha
   CTI BioPharma EPS misses by $0.02  2021/06/01 20:15:44 Seeking Alpha
   Must-See Earnings Estimates NASDAQ:RMBL NASDAQ:CALA NASDAQ:CTIC NASDAQ:URGN and #Covid-19 (#Coronavirus) impact  2021/03/21 02:58:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   CTI BioPharma (NASDAQ:CTIC) Announces Quarterly Earnings Results  2021/03/19 11:28:41 Transcript Daily
CTI BioPharma (NASDAQ:CTIC) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The firm’s 50-day moving average price is $3.32 and its 200-day moving […]
   CTI BioPharma (NASDAQ:CTIC) Releases Earnings Results, Misses Expectations By $0.04 EPS  2021/03/19 04:29:29 Daily Political
CTI BioPharma (NASDAQ:CTIC) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The stock has a market cap of $246.79 million, a P/E ratio of -4.81 and a […]
   CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results  2021/03/17 20:05:00 PR Newswire
SEATTLE, March 17, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2020. "This past quarter, CTI has executed on the critical clinical, regulatory and commercial activities that will allow…
   CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4  2021/02/25 12:00:00 PR Newswire
SEATTLE, Feb. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a virtual meeting format. Presentation details:…
   Must-See Earnings Estimates NASDAQ:RMBL NASDAQ:CALA NASDAQ:CTIC NASDAQ:URGN and #Covid-19 (#Coronavirus) impact  2021/03/21 02:58:00 Stock Market Daily
Earnings, Analyst opinion and estimate and latest Covid-19 (Coronavirus) impact on these hot stocks to invest
   CTI BioPharma (NASDAQ:CTIC) Announces Quarterly Earnings Results  2021/03/19 11:28:41 Transcript Daily
CTI BioPharma (NASDAQ:CTIC) released its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($0.20) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The firm’s 50-day moving average price is $3.32 and its 200-day moving […]
   CTI BioPharma (NASDAQ:CTIC) Releases Earnings Results, Misses Expectations By $0.04 EPS  2021/03/19 04:29:29 Daily Political
CTI BioPharma (NASDAQ:CTIC) issued its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.04), MarketWatch Earnings reports. Shares of NASDAQ CTIC opened at $3.27 on Friday. The stock has a market cap of $246.79 million, a P/E ratio of -4.81 and a […]
   CTI BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results  2021/03/17 20:05:00 PR Newswire
SEATTLE, March 17, 2021 /PRNewswire/ -- CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the fourth quarter and full year ended December 31, 2020. "This past quarter, CTI has executed on the critical clinical, regulatory and commercial activities that will allow…
   CTI BioPharma to Present at the Cowen 41st Annual Health Care Conference on Thursday, Mar. 4  2021/02/25 12:00:00 PR Newswire
SEATTLE, Feb. 25, 2021 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Cowen 41st Annual Health Care Conference at 12:10 p.m. EST. The conference will be held in a virtual meeting format. Presentation details:…

calendar